Related references
Note: Only part of the references are listed.Genetic Obesity and Bariatric Surgery Outcome in 1014 Patients with Morbid Obesity
M. I. Cooiman et al.
OBESITY SURGERY (2020)
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clement et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension
Morgane Baron et al.
NATURE MEDICINE (2019)
Human Semaphorin 3 Variants Link Melanocortin Circuit Development and Energy Balance
Agatha A. van der Klaauw et al.
CELL (2019)
Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations
Adriana Nunziata et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment
Kristin L. Ayers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Loss-of-function mutations in ADCY3 cause monogenic severe obesity
Sadia Saeed et al.
NATURE GENETICS (2018)
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
Karine Clement et al.
NATURE MEDICINE (2018)
Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls
Gry B. N. Nordang et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Functional and clinical relevance of novel and known PCSK1 variants for childhood obesity and glucose metabolism
Dennis Loeffler et al.
MOLECULAR METABOLISM (2017)
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
Tinh-Hai Collet et al.
MOLECULAR METABOLISM (2017)
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
Rajarshi Ghosh et al.
GENOME BIOLOGY (2017)
Genetic and environmental effects on body mass index from infancy to the onset of adulthood: an individual-based pooled analysis of 45 twin cohorts participating in the COllaborative project of Development of Anthropometrical measures in Twins (CODATwins) study
Karri Silventoinen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
UMD-Predictor: A High-Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA Substitution
David Salgado et al.
HUMAN MUTATION (2016)
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Peter Kuehnen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016
Helene Huvenne et al.
OBESITY FACTS (2016)
PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels
Yongwook Choi et al.
BIOINFORMATICS (2015)
The Hunger Genes: Pathways to Obesity
Agatha A. van der Klaauw et al.
CELL (2015)
Revisiting PC1/3 Mutants: Dominant-Negative Effect of Endoplasmic Reticulum-Retained Mutants
Elias H. Blanco et al.
ENDOCRINOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Seven Novel Deleterious LEPR Mutations Found in Early-Onset Obesity: a ΔExon6-8 Shared by Subjects From Reunion Island, France, Suggests a Founder Effect
Helene Huvenne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity
Ilanit Bomer et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2015)
A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity
J. Philippe et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus
I. R. Aslan et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
20 YEARS OF LEPTIN Insights into signaling assemblies of the leptin receptor
Frank Peelman et al.
JOURNAL OF ENDOCRINOLOGY (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Heterozygous Mutations Causing Partial Prohormone Convertase 1 Deficiency Contribute to Human Obesity
John W. M. Creemers et al.
DIABETES (2012)
Candidate Molecular Pathway Genes Related to Appetite Regulatory Neural Network, Adipocyte Homeostasis and Obesity: Results from the CARDIA Study
Yechiel Friedlander et al.
ANNALS OF HUMAN GENETICS (2010)
Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response
Pierre Roubert et al.
JOURNAL OF ENDOCRINOLOGY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Dynamics of Change in Total and Regional Body Composition After Gastric Bypass in Obese Patients
Cecile Ciangura et al.
OBESITY (2010)
Common nonsynonymous variants in PCSK1 confer risk of obesity
Michael Benzinou et al.
NATURE GENETICS (2008)
Mutational analysis of the pro-opiomelanocortin gene in french obese children led to the identification of a novel deleterious heterozygous mutation located in the α-melanocyte stimulating hormone domain
Beatrice Dubern et al.
PEDIATRIC RESEARCH (2008)
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor
I. Sadaf Farooqi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Melanocortin 4 receptor mutations in a large cohort of severely obese adults: Prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating
C Lubrano-Berthelier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
A role for β-melanocyte-stimulating hormone in human body-weight regulation
H Biebermann et al.
CELL METABOLISM (2006)
A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance
YS Lee et al.
CELL METABOLISM (2006)
Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY3-36
BG Challis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Obesity due to proopiomelanocortin deficiency:: Three new cases and treatment trials with thyroid hormone and ACTH4-10
H Krude et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene
IS Farooqi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism
BG Challis et al.
HUMAN MOLECULAR GENETICS (2002)
Metabolism - Partial leptin deficiency and human adiposity
IS Farooqi et al.
NATURE (2001)
Share Paper
